In the present study, we compared the effects of sucrose and arsenic intake for two months in developing the signs of MS, along with the alterations in muscle insulin signaling pathways that control GLUT4 translocation to the sarcolemma. This evidence concerns the gene SLC2A4 and myeloid sarcoma.